PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

RTTNews | vor 1028 Tagen
Stocktwits
PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Wednesday that Upstaza (eladocagene exuparvovec) was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older.

Upstaza is a one-time gene replacement therapy indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of AADC deficiency with a severe phenotype.

The marketing authorization is applicable to all 27 European Union member states, as well as Iceland, Norway and Liechtenstein.

For More Such Health News, visit rttnews.com

Tags: PTCT
Stocktwits
read more
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | vor 180 Tagen
Australian Market Slightly Lower

Australian Market Slightly Lower

Australian shares are trading slightly lower on Wednesday, snapping a five-session winning streak, with the benchmark S&P/ASX 200 staying well below the 8,300 level, following the mixed cues from Wall Street overnight, with a mixed performance across most sectors. Traders are also booking some profits following the recent upside in the markets.
RTTNews | vor 4 Minuten
China Bourse Tipped To Open In The Green

China Bourse Tipped To Open In The Green

The China stock market has moved higher in consecutive trading days, improving almost 35 points or 1 percent along the way. The Shanghai Composite Index now rests just beneath the 3,375-point plateau and it's looking at a higher open again on Wednesday.
RTTNews | vor 13 Minuten
Tech Shares May Boost Taiwan Stock Market

Tech Shares May Boost Taiwan Stock Market

The Taiwan stock market has moved higher in three straight sessions, collecting almost 800 points or 4 percent in that span. The Taiwan Stock Exchange now sits just above the 21,330-point plateau and it's likely to open to the upside again on Wednesday.
RTTNews | vor 43 Minuten
Japan Producer Prices Rise 0.2% In April

Japan Producer Prices Rise 0.2% In April

Producer prices in Japan were up 0.2 percent on month in April, the Bank of Japan said on Wednesday - slowing from 0.4 percent in March.
RTTNews | vor 47 Minuten
Singapore Bourse May Crack Resistance At 3,900 Points

Singapore Bourse May Crack Resistance At 3,900 Points

The Singapore stock market has tracked higher in back-to-back sessions, gathering more than 30 points or 0.8 percent along the way. The Straits Times Index now sits just above the 3,880-point plateau and it may see additional support on Wednesday.
RTTNews | vor 1Std 13 Minuten
Malaysia Shares Expected To Open To The Upside On Wednesday

Malaysia Shares Expected To Open To The Upside On Wednesday

The Malaysia stock market has moved higher in two straight sessions, advancing almost 40 points or 2.7 percent in that span. The Kuala Lumpur Composite Index now sits just above the 1,580-point plateau and it may extend its gains again on Wednesday.
RTTNews | vor 1Std 43 Minuten
Tools
Wirtschaftskalender
Market Hours
Interest Rates
Holidays Calendar
Forex-Markt
Forex-Volatilität
Forex-Korrelation
Forex-Nachrichten
forex analysis
COT-Daten
Liquidität
Forex-Rechner
Forex Heat-Map
Indicators Heatmap
Community
Community
Systeme
Beliebteste Systeme
Strategien
Wettbewerbe
Forex-Charts
Forex-Sentiment
Prognoseindikator
Bewertungen
Broker
Prop Trading Firms
VPS-Dienste
Signalanbieter
EA Programmierdienstleistungen
Affiliate Programs
PAMM - Broker-Dienstleistungen
Rabattprogramm-Dienstleistungen
Handelsplattformen
Expertenberater
Krypto-Börsen
Trading Courses
Broker
Forex-Spreads
Forex-Broker-Kotierungen
Forex-Broker-Swaps
Volumen des Forex-Brokers
Forex-Broker-Aktionen Press Release
Plattform
Widgets
Funktionen
API
RSS
Stock Portfolio
Affiliate Software
Erweiterte Charts
Betreuung
FAQ
Hilfe
Kontaktieren Sie uns
Fehler melden!
Über uns
Blog
© 2025 Myfxbook Ltd. Alle Rechte vorbehalten.
WARNUNG VOR HOHEM RISIKO: Der Devisenhandel birgt ein hohes Risiko, das möglicherweise nicht für alle Anleger geeignet ist. Der Einsatz von Leverage schafft zusätzliches Risiko und Verlustgefahr. Bevor Sie sich für den Devisenhandel entscheiden, sollten Sie Ihre Anlageziele, Ihr Erfahrungsniveau und Ihre Risikotoleranz sorgfältig prüfen. Sie könnten Ihre ursprüngliche Investition teilweise oder ganz verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren. Informieren Sie sich über die mit dem Devisenhandel verbundenen Risiken und lassen Sie sich von einem unabhängigen Finanz- oder Steuerberater beraten, wenn Sie Fragen haben. Alle Daten und Informationen werden ausschließlich zu Informationszwecken bereitgestellt und sind nicht für Handelszwecke oder Beratung gedacht. Die vergangene Performance ist kein Indikator für zukünftige Ergebnisse.